Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IODIXANOL Cause Acute generalised exanthematous pustulosis? 77 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Acute generalised exanthematous pustulosis have been filed in association with IODIXANOL (Iodixanol). This represents 3.7% of all adverse event reports for IODIXANOL.

77
Reports of Acute generalised exanthematous pustulosis with IODIXANOL
3.7%
of all IODIXANOL reports
0
Deaths
35
Hospitalizations

How Dangerous Is Acute generalised exanthematous pustulosis From IODIXANOL?

Of the 77 reports, 35 (45.5%) required hospitalization, and 7 (9.1%) were considered life-threatening.

Is Acute generalised exanthematous pustulosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IODIXANOL. However, 77 reports have been filed with the FAERS database.

What Other Side Effects Does IODIXANOL Cause?

Pruritus (307) Rash (212) Erythema (176) Urticaria (154) Dyspnoea (148) Acute kidney injury (116) Nausea (95) Anaphylactic reaction (91) Hypotension (90) Vomiting (83)

What Other Drugs Cause Acute generalised exanthematous pustulosis?

VANCOMYCIN (417) AMOXICILLIN (408) CLINDAMYCIN (330) ACETAMINOPHEN (321) SULFAMETHOXAZOLE\TRIMETHOPRIM (285) CEFTRIAXONE (261) IBUPROFEN (258) PIPERACILLIN\TAZOBACTAM (257) ENOXAPARIN (251) VALACYCLOVIR (239)

Which IODIXANOL Alternatives Have Lower Acute generalised exanthematous pustulosis Risk?

IODIXANOL vs IOHEXOL IODIXANOL vs IOMEPROL IODIXANOL vs IOPAMIDOL IODIXANOL vs IOPROMIDE IODIXANOL vs IOTHALAMIC ACID

Related Pages

IODIXANOL Full Profile All Acute generalised exanthematous pustulosis Reports All Drugs Causing Acute generalised exanthematous pustulosis IODIXANOL Demographics